Clinical Study

Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Participants With Early Stage Relapsing Remitting Multiple Sclerosis (Rrms)

Posted Date: May 15, 2019

  • Investigator: Aram Zabeti
  • Type of Study: Drug

Consonance MN39159


-Have A Definite Diagnosis Of Rrms, As Per The Revised Mcdonald 2010 Criteria -Have A Length Of Dis


Ocrelizumab , Relapsing Remitting

For More Information:

Molly Winters

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.